Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEPress Release▲ PositiveResults29 Jul 2026

OnEMI Technology Solutions Limited

Press Release

OnEMI Technology Solutions Limited, also known as Kissht, has announced its unaudited financial results for the quarter ended June 30, 2026, reporting a 61% YoY growth in AUM to ₹8,001 Cr and a 59% YoY increase in PAT to ₹95 Cr.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults29 Jul 2026

Adani Power Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Adani Power Limited has informed the Exchange about the transcript of the Investors / Analysts Conference Call held on July 23, 2026, for Q1 FY27 Financial Results. The company reported its highest ever quarterly power generation of 31 billion units and dispatched 28.8 billion units, a growth of 17%. The company's total continuing revenue for the first quarter of FY27 is INR17,936 crores, a growth of 27% over the corresponding quarter of FY26. Continuing EBITDA without prior period items for the quarter is INR6,983 crores, which is 22% higher year-on-year. The company has reported 47% higher profit after tax on year-on-year at INR4,867 crores for quarter 1 FY27.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults29 Jul 2026

Adani Power Ltd

Adani Power Limited has submitted to the Exchange, a copy of the Earnings Call Transcript

Adani Power Ltd has announced its Q1 FY27 earnings, with a 27% growth in total continuing revenue to INR17,936 crores, and a 22% increase in continuing EBITDA to INR6,983 crores. The company has also reported a 47% higher profit after tax at INR4,867 crores. Additionally, Adani Power has acquired a 180-MW Churk power plant and a 24% stake in Jaiprakash Power Ventures and an 11.49% stake in Prayagraj Power Generation Company.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults29 Jul 2026

ADF Foods Limited

Press Release

ADF Foods Limited has announced its Q1 FY27 financial results, reporting a 25.9% year-on-year growth in consolidated revenue to Rs. 167.3 Cr, with EBITDA increasing by 26.0% to Rs. 29.7 Cr and PAT increasing by 13.4% to Rs. 17.3 Cr.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults29 Jul 2026

Hexaware Technologies Ltd

Please Find Enclosed

Hexaware Technologies Ltd has announced its financial results for the quarter and six months ended June 30, 2026, with revenue of USD 405.4 Mn and INR 38,452 Mn, and EBIT of 13.6%. The company has also highlighted its key financial and business highlights, including the pivot to AI, rapid growth in profitability, and significant team expansion.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults29 Jul 2026

OnEMI Technology Solutions Ltd

Investor presentation on Unaudited Financial Results for the quarter ended June 30, 2026.

OnEMI Technology Solutions Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a 61% YoY increase in AUM to ₹8,001 crore, driven by continued portfolio expansion and underwriting and collections discipline. The company has also reported a 59% YoY growth in PAT to ₹95 crore in Q1FY27.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults29 Jul 2026

Laxmi Organic Industries Limited

Investor Presentation

Laxmi Organic Industries Limited has informed the Exchange about Investor Presentation for Q1 FY27, with strong double-digit revenue growth across the portfolio driven by volumes and prices, and higher realizations and operating leverage supporting strong margin growth.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults29 Jul 2026

EFC (I) Limited

Press Release

EFC (I) Limited, a leading real estate-as-a-service platform, has announced its Q1 FY27 financial results, reflecting consistent and accelerating YoY growth. The company's diversified service ecosystem and expanding national footprint continue to reinforce its market position.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults29 Jul 2026

Piramal Pharma Ltd

Please see enclosed Investor Presentation for Q1 FY 27

Piramal Pharma Ltd has announced its Q1 FY27 results, showing a 17% revenue growth, with EBITDA increasing by 72% and EBITDA margin expanding by 400 basis points to 12.5%. The company's CDMO business delivered broad-based growth, while the Complex Hospital Generics business maintained leadership in key therapies and gained traction in ex-US inhalation anesthesia markets.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults29 Jul 2026

Hexaware Technologies Limited

Outcome of Board Meeting

Hexaware Technologies Limited has submitted its financial results for the quarter and six months ended June 30, 2026, with the Board of Directors approving the unaudited standalone and consolidated financial results. The results will be published in newspapers and on the company's website.

Read more →📎 1 attachment
NSEUpdates▲ PositiveResults29 Jul 2026

Happiest Minds Technologies Limited

Updates

Happiest Minds Technologies Limited has informed the Exchange regarding 'Communication To Shareholders - Financial Results For The Quarter Ended June 30, 2026'. The company has reported operating revenue of ₹629 crore, representing 14.3% year-on-year and 4.0% sequential growth in rupee terms. Adjusted PAT increased 14.7% year-on-year to ₹80.5 crore and Adjusted EPS grew 17.1% to ₹5.34.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults29 Jul 2026

EFC (I) Limited

Analysts/Institutional Investor Meet/Con. Call Updates

EFC (I) Limited has informed the Exchange about Presentation for Q1 FY27, with revenue at ₹2,829 Mn, representing growth of 29% YoY, and segmental revenue of ₹1,539 Mn, ₹1,004 Mn, and ₹286 Mn for Leasing, Design & Build, and Furniture respectively.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults29 Jul 2026

EFC (I) Limited

Investor Presentation

EFC (I) Limited has informed the Exchange about Investor Presentation, with Q1 FY27 revenue of ₹2,829 Mn, representing a 29% YoY growth, and EBITDA and PAT of ₹1,230 Mn and ₹709 Mn respectively. The company's performance was driven by disciplined execution, sustained enterprise demand, and a sharper focus on profitable, capital-efficient growth.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults29 Jul 2026

Piramal Pharma Limited

Investor Presentation

Piramal Pharma Limited has announced its Q1 FY27 results, with a 17% revenue growth, 72% EBITDA growth, and 12.5% EBITDA margin expansion. The company's CDMO business delivered broad-based growth, while its Complex Hospital Generics and Consumer Healthcare businesses maintained leadership positions in their respective markets.

Read more →📎 1 attachment
← PreviousPage 468 of 541Next →